Detailed instructions for use of the new multiple myeloma drug Ixazomib

Ixazomib capsules are an oral, highly selective proteasome inhibitor developed by Takeda Pharmaceuticals. It is mainly used to treat patients with multiple myeloma (MM) who have received at least one type of therapy in the past. Ixazomib is usually used in combination with lenalidomide and dexamethasone to inhibit the growth and spread of tumor cells by inhibiting the activity of the proteasome and interfering with the protein degradation process in tumor cells.

1. Usage and dosage

1. Recommended starting dose: The recommended starting dose of ixazomib capsules is 4mg each time, taken orally once a week on days 1, 8 and 15 of a 28-day treatment cycle.

2. Administration time: Administration should be done at the same time every day to ensure stable drug concentration. It is recommended to take it at least one hour before or two hours after a meal.

3. How to take: Ixazomib capsules should be swallowed whole and should not be crushed, chewed or opened. It should be taken with water to ensure that the medicine completely enters the body.

4. Handling of missed doses: If you miss a dose and the time interval between the next scheduled dose exceeds72 hours, you should take it immediately. If it is less than 72 hours before the next dose, there is no need to take a supplementary dose, just continue taking the medicine at the original dose and time.

2. Precautions

1. Drug allergy: It is contraindicated in patients who are allergic to ixazomib or any of its ingredients.

2. Liver and kidney function: Patients with impaired liver and kidney function should use it with caution and adjust the dosage under the guidance of a doctor.

3. Pregnancy and lactation: Ixazomib may have adverse effects on the fetus, so effective contraceptive measures should be taken during administration and for at least90 days after the last dose. At the same time, lactating women should stop breastfeeding while taking the medicine.

4. Drug interactions: Avoid simultaneous use with potentCyp3A inducers to avoid reducing the efficacy of ixazomib.

5. Monitoring indicators: During the treatment period, the patient's platelet count, liver and kidney function and other indicators should be regularly monitored in order to promptly detect and deal with possible side effects or adverse reactions.

3. Adverse reactions

Common adverse reactions of ixazomib capsules include thrombocytopenia, neutropenia, diarrhea, constipation, peripheral neuropathy, etc. If serious adverse reactions occur or symptoms continue to worsen, you should seek medical treatment immediately and inform the doctor that you are using ixazomib capsules.

4. Storage and safekeeping

Please store ixazomib capsules in a cool, dry place away from direct sunlight and moisture. Keep medicines out of the reach of children.

5. Specifications and selling price

It is understood that ixazomib has been launched in China and is sold in different specifications, including4mg*1 tablet*3 tablets, 3mg*1 tablet*3 tablets and 2.3mg*1 tablet*3 tablets. Please consult the hospital pharmacy for specific drug pricing, which may vary by region. There is also a cheap generic version on the Laos market, produced by Lucius Pharmaceuticals. Each box (4mg*3 pills) sells for about 900 yuan.

The above is the detailed instructions for use of ixazomib capsules. When using this medicine, be sure to follow your doctor's advice and guidance to ensure its safety and effectiveness. If you have any questions or discomfort, please consult your doctor promptly.